| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 123 | 2025 | 13586 | 6.360 |
Why?
|
| Carcinoma, Pancreatic Ductal | 68 | 2024 | 1757 | 5.640 |
Why?
|
| Pancreatic Neoplasms | 98 | 2024 | 5446 | 5.300 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 59 | 2024 | 5432 | 4.440 |
Why?
|
| Adenocarcinoma, Mucinous | 39 | 2024 | 526 | 4.340 |
Why?
|
| Adenocarcinoma | 63 | 2024 | 6395 | 3.920 |
Why?
|
| Pancreatic Cyst | 17 | 2021 | 372 | 2.380 |
Why?
|
| Barrett Esophagus | 14 | 2014 | 495 | 2.050 |
Why?
|
| Immunohistochemistry | 55 | 2022 | 11095 | 1.800 |
Why?
|
| Pancreas | 27 | 2021 | 1700 | 1.590 |
Why?
|
| Small Cell Lung Carcinoma | 9 | 2025 | 454 | 1.510 |
Why?
|
| Neoplasm Staging | 43 | 2024 | 11244 | 1.470 |
Why?
|
| Pancreatic Ducts | 13 | 2022 | 330 | 1.410 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 8 | 2023 | 195 | 1.380 |
Why?
|
| Carcinoma, Papillary | 18 | 2021 | 793 | 1.370 |
Why?
|
| Cytodiagnosis | 9 | 2021 | 452 | 1.370 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 12 | 2024 | 1105 | 1.340 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 16 | 2017 | 1627 | 1.290 |
Why?
|
| Esophageal Neoplasms | 13 | 2018 | 1668 | 1.250 |
Why?
|
| Pancreatectomy | 19 | 2021 | 825 | 1.250 |
Why?
|
| Precancerous Conditions | 12 | 2017 | 985 | 1.230 |
Why?
|
| Lung | 25 | 2024 | 10099 | 1.120 |
Why?
|
| Neoplasm Invasiveness | 29 | 2024 | 3620 | 1.100 |
Why?
|
| Mutation | 60 | 2024 | 30238 | 1.060 |
Why?
|
| Antibodies | 5 | 2021 | 2421 | 0.980 |
Why?
|
| Humans | 393 | 2025 | 768166 | 0.960 |
Why?
|
| Esophagus | 12 | 2014 | 1042 | 0.940 |
Why?
|
| Neoplasm Recurrence, Local | 24 | 2025 | 9419 | 0.940 |
Why?
|
| Pathology | 3 | 2024 | 270 | 0.920 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 8 | 2024 | 521 | 0.850 |
Why?
|
| Carcinoma in Situ | 7 | 2019 | 788 | 0.850 |
Why?
|
| Esophagoscopy | 7 | 2014 | 398 | 0.840 |
Why?
|
| Microsatellite Instability | 6 | 2016 | 726 | 0.830 |
Why?
|
| Aged | 171 | 2025 | 171504 | 0.820 |
Why?
|
| Proto-Oncogene Proteins B-raf | 10 | 2021 | 2059 | 0.820 |
Why?
|
| Tumor Microenvironment | 20 | 2024 | 3948 | 0.790 |
Why?
|
| Gastric Mucosa | 12 | 2019 | 602 | 0.780 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 19 | 2023 | 1767 | 0.780 |
Why?
|
| Drug Resistance, Neoplasm | 23 | 2024 | 5341 | 0.770 |
Why?
|
| Prognosis | 48 | 2024 | 30010 | 0.760 |
Why?
|
| Thoracic Neoplasms | 1 | 2024 | 269 | 0.750 |
Why?
|
| Biopsy | 28 | 2022 | 6793 | 0.750 |
Why?
|
| Alveolitis, Extrinsic Allergic | 4 | 2017 | 62 | 0.740 |
Why?
|
| Protein Kinase Inhibitors | 28 | 2022 | 5703 | 0.740 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2018 | 117 | 0.730 |
Why?
|
| Aged, 80 and over | 94 | 2025 | 59629 | 0.720 |
Why?
|
| Middle Aged | 174 | 2025 | 223492 | 0.720 |
Why?
|
| Diagnosis, Differential | 36 | 2022 | 13014 | 0.690 |
Why?
|
| Male | 213 | 2025 | 364719 | 0.690 |
Why?
|
| Pathology, Molecular | 2 | 2020 | 329 | 0.690 |
Why?
|
| Lung Diseases, Interstitial | 5 | 2024 | 940 | 0.670 |
Why?
|
| Female | 206 | 2025 | 397192 | 0.620 |
Why?
|
| Stomach Neoplasms | 10 | 2019 | 1481 | 0.590 |
Why?
|
| Colorectal Neoplasms | 14 | 2019 | 6974 | 0.590 |
Why?
|
| Observer Variation | 10 | 2024 | 2622 | 0.570 |
Why?
|
| Tomography, Optical Coherence | 14 | 2022 | 2957 | 0.570 |
Why?
|
| Antibodies, Monoclonal | 10 | 2021 | 9263 | 0.560 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 452 | 0.540 |
Why?
|
| ras Proteins | 8 | 2020 | 1058 | 0.530 |
Why?
|
| Epithelial Cells | 9 | 2021 | 3703 | 0.530 |
Why?
|
| Cyst Fluid | 5 | 2021 | 86 | 0.530 |
Why?
|
| Pancreatitis | 9 | 2015 | 1087 | 0.530 |
Why?
|
| Pathology, Clinical | 9 | 2017 | 375 | 0.530 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 15 | 2025 | 11878 | 0.520 |
Why?
|
| Photochemotherapy | 7 | 2020 | 830 | 0.520 |
Why?
|
| Translocation, Genetic | 3 | 2016 | 1394 | 0.510 |
Why?
|
| Adult | 116 | 2025 | 223646 | 0.490 |
Why?
|
| Intestinal Mucosa | 14 | 2020 | 3044 | 0.490 |
Why?
|
| Cystadenoma, Serous | 3 | 2021 | 100 | 0.490 |
Why?
|
| Immunodominant Epitopes | 1 | 2016 | 244 | 0.480 |
Why?
|
| Adenocarcinoma, Papillary | 5 | 2014 | 86 | 0.480 |
Why?
|
| Endosonography | 11 | 2023 | 626 | 0.460 |
Why?
|
| Celiac Disease | 4 | 2020 | 820 | 0.460 |
Why?
|
| Pyrazoles | 13 | 2022 | 2028 | 0.460 |
Why?
|
| Carcinoma, Squamous Cell | 14 | 2024 | 4058 | 0.460 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2016 | 308 | 0.460 |
Why?
|
| Pain, Intractable | 1 | 2015 | 132 | 0.460 |
Why?
|
| Pleural Neoplasms | 4 | 2022 | 612 | 0.450 |
Why?
|
| Protein-Tyrosine Kinases | 10 | 2023 | 2433 | 0.450 |
Why?
|
| Gene Rearrangement | 6 | 2024 | 1146 | 0.440 |
Why?
|
| Carcinoma | 3 | 2021 | 2332 | 0.430 |
Why?
|
| Aspergillus flavus | 1 | 2013 | 13 | 0.430 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2019 | 3814 | 0.420 |
Why?
|
| Reproducibility of Results | 23 | 2022 | 20227 | 0.420 |
Why?
|
| In Situ Hybridization, Fluorescence | 16 | 2022 | 2521 | 0.420 |
Why?
|
| Carcinoma, Neuroendocrine | 3 | 2023 | 343 | 0.410 |
Why?
|
| Neoplasm Proteins | 4 | 2021 | 3603 | 0.410 |
Why?
|
| Nuclear Proteins | 5 | 2021 | 5804 | 0.410 |
Why?
|
| Mucins | 5 | 2009 | 570 | 0.400 |
Why?
|
| Esophageal Cyst | 1 | 2012 | 13 | 0.400 |
Why?
|
| Pathology, Surgical | 4 | 2016 | 148 | 0.390 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2012 | 31 | 0.390 |
Why?
|
| Retrospective Studies | 58 | 2024 | 81762 | 0.390 |
Why?
|
| Aspergillus fumigatus | 1 | 2013 | 158 | 0.380 |
Why?
|
| Tissue Array Analysis | 5 | 2019 | 551 | 0.380 |
Why?
|
| Proto-Oncogene Proteins | 11 | 2023 | 4528 | 0.380 |
Why?
|
| Gene Expression Regulation, Neoplastic | 23 | 2024 | 8647 | 0.380 |
Why?
|
| Toxoplasmosis | 1 | 2012 | 94 | 0.380 |
Why?
|
| Colonic Neoplasms | 8 | 2019 | 2541 | 0.380 |
Why?
|
| Tomography, X-Ray Computed | 30 | 2024 | 20760 | 0.380 |
Why?
|
| Immunotherapy | 11 | 2024 | 4755 | 0.370 |
Why?
|
| Pulmonary Fibrosis | 5 | 2017 | 506 | 0.370 |
Why?
|
| Autopsy | 3 | 2020 | 1011 | 0.370 |
Why?
|
| Sensitivity and Specificity | 23 | 2021 | 14729 | 0.370 |
Why?
|
| Brain Abscess | 1 | 2012 | 123 | 0.360 |
Why?
|
| Colon, Sigmoid | 2 | 2010 | 124 | 0.360 |
Why?
|
| Lung Diseases, Fungal | 1 | 2011 | 124 | 0.360 |
Why?
|
| Cryptococcosis | 1 | 2011 | 103 | 0.360 |
Why?
|
| Fatal Outcome | 5 | 2020 | 1836 | 0.360 |
Why?
|
| Conscious Sedation | 1 | 2015 | 534 | 0.360 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2024 | 1801 | 0.350 |
Why?
|
| Proto-Oncogene Proteins c-met | 5 | 2020 | 564 | 0.350 |
Why?
|
| Cell Line, Tumor | 31 | 2024 | 17140 | 0.350 |
Why?
|
| Pyridines | 9 | 2020 | 2894 | 0.350 |
Why?
|
| Pemphigus | 1 | 2011 | 107 | 0.350 |
Why?
|
| Xenograft Model Antitumor Assays | 15 | 2020 | 3611 | 0.340 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2022 | 2810 | 0.340 |
Why?
|
| Adenoma | 6 | 2021 | 2159 | 0.340 |
Why?
|
| Antineoplastic Agents | 17 | 2020 | 13676 | 0.340 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2012 | 162 | 0.340 |
Why?
|
| Genes, erbB-1 | 3 | 2017 | 163 | 0.340 |
Why?
|
| Neutrophil Infiltration | 1 | 2012 | 393 | 0.340 |
Why?
|
| Esophagogastric Junction | 2 | 2011 | 351 | 0.330 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2018 | 4063 | 0.330 |
Why?
|
| Dihematoporphyrin Ether | 3 | 2011 | 33 | 0.320 |
Why?
|
| Influenza, Human | 1 | 2020 | 1541 | 0.320 |
Why?
|
| Neuroendocrine Tumors | 3 | 2022 | 659 | 0.320 |
Why?
|
| Duodenum | 1 | 2012 | 495 | 0.320 |
Why?
|
| Ampulla of Vater | 4 | 2015 | 150 | 0.320 |
Why?
|
| DNA Mutational Analysis | 10 | 2021 | 4120 | 0.320 |
Why?
|
| Deoxycytidine | 3 | 2020 | 887 | 0.320 |
Why?
|
| Neoadjuvant Therapy | 9 | 2024 | 2907 | 0.310 |
Why?
|
| Chromogranins | 3 | 2018 | 160 | 0.310 |
Why?
|
| Mucin-1 | 2 | 2018 | 537 | 0.300 |
Why?
|
| Autoimmune Diseases | 8 | 2011 | 2257 | 0.300 |
Why?
|
| Lung Diseases | 7 | 2021 | 1944 | 0.300 |
Why?
|
| Epidermal Growth Factor | 1 | 2011 | 697 | 0.300 |
Why?
|
| Analgesics | 1 | 2015 | 1071 | 0.300 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2023 | 2474 | 0.300 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 8 | 2023 | 905 | 0.300 |
Why?
|
| Gastritis | 3 | 2019 | 199 | 0.290 |
Why?
|
| Neoplasms | 10 | 2024 | 22371 | 0.290 |
Why?
|
| Lactams, Macrocyclic | 3 | 2022 | 319 | 0.290 |
Why?
|
| Oncogene Proteins, Fusion | 5 | 2018 | 1613 | 0.290 |
Why?
|
| Disease-Free Survival | 9 | 2021 | 6847 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2022 | 2846 | 0.290 |
Why?
|
| Neoplasms, Multiple Primary | 3 | 2024 | 594 | 0.290 |
Why?
|
| Intestinal Polyps | 1 | 2008 | 105 | 0.290 |
Why?
|
| Neoplastic Cells, Circulating | 4 | 2016 | 952 | 0.290 |
Why?
|
| Tumor Burden | 8 | 2019 | 1906 | 0.290 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 3 | 2018 | 194 | 0.290 |
Why?
|
| Bronchoscopy | 4 | 2021 | 914 | 0.290 |
Why?
|
| Photosensitizing Agents | 4 | 2011 | 629 | 0.290 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2009 | 264 | 0.280 |
Why?
|
| Kaplan-Meier Estimate | 12 | 2018 | 6526 | 0.280 |
Why?
|
| Lymphatic Metastasis | 8 | 2024 | 2914 | 0.280 |
Why?
|
| Bile Duct Neoplasms | 4 | 2017 | 614 | 0.280 |
Why?
|
| Tracheal Neoplasms | 2 | 2019 | 124 | 0.280 |
Why?
|
| Endoscopy | 4 | 2017 | 1854 | 0.280 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2024 | 4648 | 0.270 |
Why?
|
| Radiography | 12 | 2018 | 6983 | 0.270 |
Why?
|
| Solitary Fibrous Tumor, Pleural | 2 | 2019 | 25 | 0.270 |
Why?
|
| Acetamides | 2 | 2020 | 259 | 0.270 |
Why?
|
| MAP Kinase Signaling System | 4 | 2015 | 1494 | 0.270 |
Why?
|
| Esophageal Diseases | 4 | 2012 | 167 | 0.270 |
Why?
|
| Stomach Diseases | 2 | 2007 | 134 | 0.260 |
Why?
|
| Azepines | 2 | 2020 | 329 | 0.260 |
Why?
|
| Metaplasia | 5 | 2016 | 326 | 0.260 |
Why?
|
| Transcription Factors | 5 | 2023 | 12168 | 0.260 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2019 | 1120 | 0.260 |
Why?
|
| Survival Rate | 16 | 2024 | 12840 | 0.260 |
Why?
|
| Cytoskeletal Proteins | 2 | 2018 | 1327 | 0.260 |
Why?
|
| Duodenitis | 2 | 2020 | 20 | 0.250 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3115 | 0.250 |
Why?
|
| CA-19-9 Antigen | 3 | 2022 | 109 | 0.250 |
Why?
|
| Endoscopy, Gastrointestinal | 4 | 2007 | 888 | 0.250 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3238 | 0.250 |
Why?
|
| Common Bile Duct Neoplasms | 3 | 2015 | 121 | 0.250 |
Why?
|
| Artifacts | 2 | 2024 | 1926 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2013 | 725 | 0.250 |
Why?
|
| Mice | 45 | 2024 | 82029 | 0.250 |
Why?
|
| Abdominal Pain | 4 | 2020 | 1070 | 0.240 |
Why?
|
| Animals | 74 | 2024 | 169246 | 0.240 |
Why?
|
| Acrylamides | 2 | 2018 | 261 | 0.240 |
Why?
|
| Neutrophils | 2 | 2021 | 3786 | 0.240 |
Why?
|
| Colitis | 5 | 2019 | 1242 | 0.240 |
Why?
|
| Biopsy, Fine-Needle | 5 | 2016 | 1135 | 0.240 |
Why?
|
| Natural Orifice Endoscopic Surgery | 3 | 2011 | 119 | 0.240 |
Why?
|
| Microscopy, Confocal | 5 | 2017 | 1972 | 0.240 |
Why?
|
| Preoperative Period | 5 | 2022 | 565 | 0.240 |
Why?
|
| Cysts | 2 | 2023 | 685 | 0.240 |
Why?
|
| Antibody Specificity | 2 | 2019 | 1065 | 0.230 |
Why?
|
| Papillomavirus Infections | 3 | 2022 | 1640 | 0.230 |
Why?
|
| Esophagectomy | 2 | 2009 | 481 | 0.230 |
Why?
|
| Hemangiosarcoma | 2 | 2023 | 215 | 0.230 |
Why?
|
| Adenomatous Polyps | 2 | 2019 | 109 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2019 | 354 | 0.230 |
Why?
|
| Liver | 5 | 2021 | 7577 | 0.220 |
Why?
|
| Intestine, Small | 4 | 2020 | 1217 | 0.220 |
Why?
|
| Cardia | 3 | 2014 | 61 | 0.220 |
Why?
|
| Neoplasm, Residual | 4 | 2021 | 1015 | 0.220 |
Why?
|
| Molecular Targeted Therapy | 8 | 2016 | 2830 | 0.220 |
Why?
|
| Respiratory Insufficiency | 2 | 2023 | 1240 | 0.220 |
Why?
|
| Mucin 5AC | 7 | 2020 | 96 | 0.220 |
Why?
|
| Predictive Value of Tests | 9 | 2021 | 15454 | 0.220 |
Why?
|
| Ornithine-Oxo-Acid Transaminase | 1 | 2023 | 49 | 0.210 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2019 | 565 | 0.210 |
Why?
|
| Peptide Fragments | 1 | 2016 | 5151 | 0.210 |
Why?
|
| Cystic Fibrosis | 2 | 2010 | 1294 | 0.210 |
Why?
|
| Azetidines | 1 | 2024 | 152 | 0.210 |
Why?
|
| Cytomegalovirus | 1 | 2007 | 753 | 0.210 |
Why?
|
| Young Adult | 30 | 2022 | 60066 | 0.210 |
Why?
|
| Signal Transduction | 18 | 2024 | 23645 | 0.210 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2003 | 77 | 0.210 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2024 | 146 | 0.210 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2015 | 259 | 0.210 |
Why?
|
| Hepatitis, Chronic | 1 | 2003 | 53 | 0.210 |
Why?
|
| Cytomegalovirus Infections | 2 | 2007 | 837 | 0.210 |
Why?
|
| Bile Ducts | 2 | 2015 | 288 | 0.210 |
Why?
|
| Carbazoles | 1 | 2024 | 230 | 0.210 |
Why?
|
| Cystadenocarcinoma, Mucinous | 2 | 2013 | 51 | 0.210 |
Why?
|
| Immunity, Cellular | 2 | 2020 | 1561 | 0.210 |
Why?
|
| Fibrosis | 5 | 2024 | 2080 | 0.210 |
Why?
|
| Survival Analysis | 12 | 2021 | 10101 | 0.200 |
Why?
|
| Swine | 20 | 2015 | 5995 | 0.200 |
Why?
|
| Cough | 2 | 2019 | 598 | 0.200 |
Why?
|
| Polyamines | 1 | 2023 | 133 | 0.200 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2021 | 3780 | 0.200 |
Why?
|
| Colon | 2 | 2011 | 1801 | 0.200 |
Why?
|
| Treatment Outcome | 30 | 2025 | 65371 | 0.200 |
Why?
|
| MAP Kinase Kinase 1 | 4 | 2017 | 331 | 0.200 |
Why?
|
| Respiratory Tract Infections | 2 | 2022 | 1014 | 0.200 |
Why?
|
| Blood | 1 | 2024 | 599 | 0.200 |
Why?
|
| Sampling Studies | 2 | 2013 | 615 | 0.190 |
Why?
|
| Early Detection of Cancer | 3 | 2021 | 3239 | 0.190 |
Why?
|
| Aniline Compounds | 3 | 2018 | 1094 | 0.190 |
Why?
|
| Lymph Node Excision | 4 | 2019 | 1271 | 0.190 |
Why?
|
| Pharmacy | 1 | 2023 | 92 | 0.190 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2021 | 59 | 0.190 |
Why?
|
| Carcinoma, Signet Ring Cell | 2 | 2012 | 81 | 0.190 |
Why?
|
| Colitis, Ischemic | 1 | 2021 | 32 | 0.190 |
Why?
|
| Smad6 Protein | 1 | 2021 | 14 | 0.190 |
Why?
|
| Biology | 1 | 2023 | 292 | 0.190 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2016 | 9015 | 0.180 |
Why?
|
| Quinazolines | 5 | 2015 | 1373 | 0.180 |
Why?
|
| Mosaicism | 1 | 2024 | 480 | 0.180 |
Why?
|
| Peritoneal Neoplasms | 2 | 2020 | 714 | 0.180 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2021 | 76 | 0.180 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2021 | 61 | 0.180 |
Why?
|
| Diagnostic Imaging | 6 | 2017 | 3533 | 0.180 |
Why?
|
| Hemosiderosis | 1 | 2021 | 66 | 0.180 |
Why?
|
| Polyomavirus Infections | 1 | 2023 | 192 | 0.180 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2023 | 381 | 0.180 |
Why?
|
| Kupffer Cells | 1 | 2021 | 143 | 0.180 |
Why?
|
| Oxonic Acid | 1 | 2020 | 32 | 0.180 |
Why?
|
| Tegafur | 1 | 2020 | 40 | 0.180 |
Why?
|
| Nerve Tissue | 1 | 2021 | 78 | 0.180 |
Why?
|
| Follow-Up Studies | 20 | 2024 | 39348 | 0.180 |
Why?
|
| Cell Proliferation | 15 | 2020 | 10474 | 0.180 |
Why?
|
| Bronchial Neoplasms | 1 | 2021 | 110 | 0.180 |
Why?
|
| Plectin | 2 | 2010 | 14 | 0.180 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 1904 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 7 | 2020 | 7454 | 0.180 |
Why?
|
| Palliative Care | 2 | 2015 | 3643 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-ret | 2 | 2020 | 228 | 0.170 |
Why?
|
| DNA, Neoplasm | 4 | 2016 | 1744 | 0.170 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2016 | 489 | 0.170 |
Why?
|
| Diarrhea | 4 | 2020 | 1320 | 0.170 |
Why?
|
| Enterocolitis | 1 | 2021 | 106 | 0.170 |
Why?
|
| Chemotherapy, Adjuvant | 5 | 2020 | 3556 | 0.170 |
Why?
|
| Tumor Virus Infections | 1 | 2023 | 437 | 0.170 |
Why?
|
| Disease Models, Animal | 20 | 2019 | 18349 | 0.170 |
Why?
|
| Carcinoma, Small Cell | 1 | 2022 | 419 | 0.170 |
Why?
|
| Pancreaticoduodenectomy | 6 | 2021 | 515 | 0.170 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2021 | 268 | 0.170 |
Why?
|
| Fluorouracil | 5 | 2023 | 1652 | 0.170 |
Why?
|
| Aortic Valve Prolapse | 1 | 2019 | 10 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2017 | 2457 | 0.170 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2020 | 70 | 0.170 |
Why?
|
| Colonic Polyps | 2 | 2019 | 557 | 0.170 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2023 | 3671 | 0.170 |
Why?
|
| Radiology | 2 | 2023 | 2104 | 0.170 |
Why?
|
| Phospholipase D | 1 | 2019 | 70 | 0.170 |
Why?
|
| Ketone Bodies | 1 | 2019 | 76 | 0.170 |
Why?
|
| Liver Neoplasms | 5 | 2015 | 4362 | 0.160 |
Why?
|
| Chest Pain | 2 | 2019 | 1101 | 0.160 |
Why?
|
| Stomach | 3 | 2009 | 701 | 0.160 |
Why?
|
| Japan | 3 | 2020 | 1418 | 0.160 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2019 | 57 | 0.160 |
Why?
|
| Thoracoscopy | 2 | 2011 | 186 | 0.160 |
Why?
|
| Asia | 1 | 2021 | 629 | 0.160 |
Why?
|
| Cryosurgery | 1 | 2024 | 479 | 0.160 |
Why?
|
| Nomograms | 2 | 2018 | 236 | 0.160 |
Why?
|
| Pleura | 1 | 2020 | 248 | 0.160 |
Why?
|
| Piperazines | 4 | 2025 | 2554 | 0.160 |
Why?
|
| Genomics | 5 | 2023 | 5926 | 0.160 |
Why?
|
| Lymphocytosis | 2 | 2012 | 121 | 0.160 |
Why?
|
| Single-Cell Analysis | 3 | 2024 | 2540 | 0.160 |
Why?
|
| Lipoylation | 1 | 2019 | 87 | 0.160 |
Why?
|
| Stem Cells | 3 | 2019 | 3537 | 0.160 |
Why?
|
| Receptor, erbB-3 | 1 | 2019 | 142 | 0.160 |
Why?
|
| Mice, Nude | 8 | 2020 | 3623 | 0.160 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2023 | 329 | 0.160 |
Why?
|
| Pulmonary Medicine | 2 | 2017 | 223 | 0.150 |
Why?
|
| Quinolines | 1 | 2024 | 772 | 0.150 |
Why?
|
| Dyspnea | 2 | 2019 | 1352 | 0.150 |
Why?
|
| Multiprotein Complexes | 3 | 2013 | 1110 | 0.150 |
Why?
|
| Immunophenotyping | 1 | 2003 | 1864 | 0.150 |
Why?
|
| Hemangioma | 1 | 2023 | 727 | 0.150 |
Why?
|
| Disease Progression | 11 | 2024 | 13671 | 0.150 |
Why?
|
| Clone Cells | 1 | 2022 | 1670 | 0.150 |
Why?
|
| Calcitriol | 1 | 2020 | 303 | 0.150 |
Why?
|
| Collagen Type I | 2 | 2023 | 618 | 0.150 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2018 | 24 | 0.150 |
Why?
|
| Crohn Disease | 3 | 2019 | 2295 | 0.150 |
Why?
|
| Histocytochemistry | 1 | 2019 | 699 | 0.150 |
Why?
|
| Pneumothorax | 1 | 2022 | 393 | 0.150 |
Why?
|
| Prednisone | 2 | 2021 | 1567 | 0.150 |
Why?
|
| Colitis, Collagenous | 1 | 2018 | 25 | 0.150 |
Why?
|
| Jaundice | 3 | 2015 | 95 | 0.150 |
Why?
|
| RNA, Neoplasm | 1 | 2020 | 749 | 0.150 |
Why?
|
| Molecular Probes | 2 | 2017 | 309 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2021 | 1151 | 0.150 |
Why?
|
| Melanoma | 5 | 2024 | 5706 | 0.150 |
Why?
|
| Cognition Disorders | 1 | 2012 | 3980 | 0.150 |
Why?
|
| Mucoproteins | 1 | 2017 | 49 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2019 | 36743 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 3 | 2016 | 1703 | 0.140 |
Why?
|
| Glucocorticoids | 2 | 2021 | 2167 | 0.140 |
Why?
|
| Acyltransferases | 1 | 2019 | 306 | 0.140 |
Why?
|
| Pancreatitis, Chronic | 4 | 2024 | 282 | 0.140 |
Why?
|
| Drug Therapy | 2 | 2018 | 504 | 0.140 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 11101 | 0.140 |
Why?
|
| Polypharmacy | 1 | 2020 | 307 | 0.140 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 361 | 0.140 |
Why?
|
| bcl-X Protein | 3 | 2015 | 412 | 0.140 |
Why?
|
| Rectal Neoplasms | 3 | 2018 | 1183 | 0.140 |
Why?
|
| Central Nervous System | 1 | 2025 | 1346 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 2 | 2011 | 598 | 0.140 |
Why?
|
| Tyrosine | 2 | 2020 | 1427 | 0.140 |
Why?
|
| Neoplasm Metastasis | 4 | 2024 | 4912 | 0.140 |
Why?
|
| Choristoma | 2 | 2012 | 205 | 0.140 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2019 | 112 | 0.140 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2019 | 384 | 0.140 |
Why?
|
| Proto-Oncogenes | 1 | 2018 | 322 | 0.140 |
Why?
|
| Fatty Acids | 3 | 2020 | 1812 | 0.140 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2021 | 306 | 0.140 |
Why?
|
| Gene Amplification | 4 | 2015 | 1095 | 0.140 |
Why?
|
| Antigens, CD | 3 | 2021 | 4035 | 0.140 |
Why?
|
| Dermatomyositis | 2 | 1997 | 259 | 0.140 |
Why?
|
| Polymyositis | 1 | 1997 | 75 | 0.140 |
Why?
|
| Image Enhancement | 5 | 2014 | 2880 | 0.140 |
Why?
|
| Neurosciences | 1 | 2022 | 383 | 0.140 |
Why?
|
| Oncogene Proteins | 3 | 2017 | 717 | 0.140 |
Why?
|
| Liver Cirrhosis | 2 | 2009 | 1960 | 0.140 |
Why?
|
| Azacitidine | 2 | 2017 | 336 | 0.140 |
Why?
|
| Myocarditis | 1 | 2024 | 802 | 0.140 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2011 | 2442 | 0.140 |
Why?
|
| Necrosis | 5 | 2013 | 1616 | 0.140 |
Why?
|
| In Situ Hybridization | 4 | 2017 | 1903 | 0.130 |
Why?
|
| Microspheres | 2 | 2011 | 788 | 0.130 |
Why?
|
| Platelet Factor 4 | 1 | 2016 | 132 | 0.130 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2018 | 286 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 6 | 2014 | 6082 | 0.130 |
Why?
|
| Peritoneum | 1 | 2017 | 230 | 0.130 |
Why?
|
| Apoptosis | 6 | 2020 | 9523 | 0.130 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 832 | 0.130 |
Why?
|
| Sulfonamides | 4 | 2015 | 1982 | 0.130 |
Why?
|
| DNA Methylation | 5 | 2017 | 4428 | 0.130 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 1104 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 481 | 0.130 |
Why?
|
| Piperidines | 1 | 2024 | 1667 | 0.130 |
Why?
|
| Pneumonia | 2 | 2022 | 2163 | 0.130 |
Why?
|
| Cell Lineage | 3 | 2024 | 2575 | 0.130 |
Why?
|
| Mesothelioma | 1 | 2022 | 811 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2013 | 2062 | 0.130 |
Why?
|
| Feasibility Studies | 13 | 2021 | 5315 | 0.130 |
Why?
|
| Pulmonary Alveoli | 2 | 2022 | 665 | 0.130 |
Why?
|
| Uveal Neoplasms | 1 | 2019 | 344 | 0.130 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 12077 | 0.130 |
Why?
|
| Fever | 4 | 2013 | 1614 | 0.130 |
Why?
|
| Skin Neoplasms | 4 | 2024 | 5863 | 0.130 |
Why?
|
| Adolescent | 24 | 2021 | 89169 | 0.130 |
Why?
|
| Epithelium | 3 | 2016 | 1607 | 0.130 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2015 | 67 | 0.120 |
Why?
|
| Leucovorin | 3 | 2023 | 643 | 0.120 |
Why?
|
| Mucin-6 | 3 | 2016 | 15 | 0.120 |
Why?
|
| Intestines | 3 | 2019 | 1909 | 0.120 |
Why?
|
| Abdominal Neoplasms | 1 | 2017 | 287 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 4 | 2023 | 7477 | 0.120 |
Why?
|
| Calgranulin B | 1 | 2015 | 87 | 0.120 |
Why?
|
| Aminopyridines | 4 | 2022 | 580 | 0.120 |
Why?
|
| Genotype | 4 | 2016 | 13045 | 0.120 |
Why?
|
| Enteroendocrine Cells | 1 | 2016 | 79 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 874 | 0.120 |
Why?
|
| Pyrimidines | 6 | 2020 | 3048 | 0.120 |
Why?
|
| Pelvic Neoplasms | 1 | 2017 | 250 | 0.120 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2015 | 194 | 0.120 |
Why?
|
| Living Donors | 1 | 1999 | 647 | 0.120 |
Why?
|
| Graft Rejection | 2 | 2016 | 4492 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2017 | 781 | 0.120 |
Why?
|
| Proportional Hazards Models | 5 | 2021 | 12543 | 0.120 |
Why?
|
| Magnetite Nanoparticles | 2 | 2014 | 312 | 0.120 |
Why?
|
| Brain | 2 | 2012 | 27360 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1695 | 0.120 |
Why?
|
| Retinoblastoma Protein | 2 | 2015 | 671 | 0.120 |
Why?
|
| Calcinosis | 2 | 2021 | 1481 | 0.120 |
Why?
|
| Drug Combinations | 1 | 2020 | 2089 | 0.110 |
Why?
|
| Lactams | 3 | 2022 | 159 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2014 | 2885 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2022 | 1162 | 0.110 |
Why?
|
| Problem-Based Learning | 1 | 2017 | 360 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2015 | 637 | 0.110 |
Why?
|
| Societies, Medical | 8 | 2020 | 3968 | 0.110 |
Why?
|
| Mediastinoscopy | 2 | 2011 | 29 | 0.110 |
Why?
|
| Europe | 1 | 2021 | 3436 | 0.110 |
Why?
|
| Biopsy, Needle | 4 | 2017 | 1622 | 0.110 |
Why?
|
| Pulmonary Emphysema | 1 | 2019 | 689 | 0.110 |
Why?
|
| Cell Movement | 4 | 2020 | 5210 | 0.110 |
Why?
|
| Neoplasm Seeding | 1 | 2014 | 85 | 0.110 |
Why?
|
| Portal Vein | 2 | 2007 | 435 | 0.110 |
Why?
|
| Mucous Membrane | 4 | 2010 | 659 | 0.110 |
Why?
|
| Caloric Restriction | 2 | 2013 | 301 | 0.110 |
Why?
|
| Ovarian Neoplasms | 3 | 2020 | 4916 | 0.110 |
Why?
|
| DNA Helicases | 2 | 2020 | 854 | 0.110 |
Why?
|
| Logistic Models | 4 | 2018 | 13290 | 0.110 |
Why?
|
| Intraoperative Care | 1 | 2017 | 770 | 0.110 |
Why?
|
| Frameshift Mutation | 1 | 2015 | 392 | 0.110 |
Why?
|
| Biliary Tract | 1 | 2014 | 135 | 0.110 |
Why?
|
| Tumor Escape | 1 | 2016 | 372 | 0.110 |
Why?
|
| Positron-Emission Tomography | 4 | 2017 | 6669 | 0.110 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 511 | 0.110 |
Why?
|
| Gene Expression Profiling | 4 | 2024 | 9538 | 0.110 |
Why?
|
| Breast Neoplasms | 6 | 2019 | 21206 | 0.110 |
Why?
|
| Cell Nucleus | 3 | 2021 | 2885 | 0.100 |
Why?
|
| Mice, Knockout | 8 | 2024 | 14488 | 0.100 |
Why?
|
| Gastroscopy | 4 | 2010 | 213 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 5 | 2020 | 6124 | 0.100 |
Why?
|
| Mice, SCID | 4 | 2020 | 2627 | 0.100 |
Why?
|
| Ferrosoferric Oxide | 1 | 2014 | 348 | 0.100 |
Why?
|
| Miniaturization | 1 | 2013 | 154 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2021 | 1397 | 0.100 |
Why?
|
| Paclitaxel | 3 | 2019 | 1733 | 0.100 |
Why?
|
| Heterozygote | 1 | 2019 | 2798 | 0.100 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 246 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 10 | 2024 | 22379 | 0.100 |
Why?
|
| Anemia, Pernicious | 1 | 2012 | 15 | 0.100 |
Why?
|
| Bronchogenic Cyst | 1 | 2012 | 28 | 0.100 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 829 | 0.100 |
Why?
|
| Stents | 3 | 2011 | 3195 | 0.100 |
Why?
|
| Immunity, Humoral | 1 | 2016 | 610 | 0.100 |
Why?
|
| Metabolomics | 1 | 2021 | 1674 | 0.100 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 125 | 0.100 |
Why?
|
| Genes, ras | 3 | 2018 | 663 | 0.100 |
Why?
|
| Laparoscopy | 2 | 2017 | 2041 | 0.100 |
Why?
|
| Loss of Heterozygosity | 3 | 2014 | 663 | 0.100 |
Why?
|
| Mass Screening | 2 | 2021 | 5458 | 0.100 |
Why?
|
| Ethanol | 2 | 2009 | 1331 | 0.100 |
Why?
|
| Paneth Cells | 1 | 2012 | 100 | 0.100 |
Why?
|
| Cohort Studies | 12 | 2020 | 41754 | 0.100 |
Why?
|
| Ferric Compounds | 1 | 2013 | 376 | 0.100 |
Why?
|
| Microvilli | 2 | 2020 | 235 | 0.100 |
Why?
|
| Cholangiocarcinoma | 1 | 2017 | 561 | 0.100 |
Why?
|
| Myocardium | 1 | 2024 | 4788 | 0.090 |
Why?
|
| raf Kinases | 1 | 2012 | 117 | 0.090 |
Why?
|
| Phenotype | 9 | 2018 | 16726 | 0.090 |
Why?
|
| Microscopy | 2 | 2024 | 909 | 0.090 |
Why?
|
| Mediastinal Diseases | 1 | 2012 | 91 | 0.090 |
Why?
|
| Erythrocyte Indices | 1 | 2012 | 143 | 0.090 |
Why?
|
| Fatty Liver | 2 | 2009 | 809 | 0.090 |
Why?
|
| Automation, Laboratory | 1 | 2012 | 102 | 0.090 |
Why?
|
| Risk Assessment | 8 | 2021 | 24315 | 0.090 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2012 | 252 | 0.090 |
Why?
|
| Lymphatic Diseases | 1 | 2013 | 319 | 0.090 |
Why?
|
| Plasma Cells | 3 | 2011 | 599 | 0.090 |
Why?
|
| Prospective Studies | 15 | 2021 | 54926 | 0.090 |
Why?
|
| Guanine | 1 | 2012 | 280 | 0.090 |
Why?
|
| Glutamates | 1 | 2012 | 385 | 0.090 |
Why?
|
| Placenta | 1 | 2020 | 1725 | 0.090 |
Why?
|
| Pulmonary Infarction | 1 | 2010 | 11 | 0.090 |
Why?
|
| Lymphocytes | 3 | 2009 | 2614 | 0.090 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2011 | 62 | 0.090 |
Why?
|
| Smad4 Protein | 3 | 2016 | 193 | 0.090 |
Why?
|
| Ornithine | 2 | 2023 | 79 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2015 | 1406 | 0.090 |
Why?
|
| Catheter Ablation | 2 | 2015 | 2780 | 0.090 |
Why?
|
| Frozen Sections | 2 | 2021 | 154 | 0.090 |
Why?
|
| Algorithms | 4 | 2019 | 14164 | 0.090 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2011 | 70 | 0.090 |
Why?
|
| Lymph Nodes | 4 | 2020 | 3474 | 0.090 |
Why?
|
| Medical Records | 1 | 2016 | 1410 | 0.090 |
Why?
|
| Proctoscopy | 1 | 2010 | 40 | 0.090 |
Why?
|
| Proteins | 2 | 2017 | 6009 | 0.090 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 934 | 0.090 |
Why?
|
| Liver Failure, Acute | 1 | 2012 | 182 | 0.090 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2022 | 2043 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2003 | 2333 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 9118 | 0.090 |
Why?
|
| Preoperative Care | 3 | 2018 | 2258 | 0.090 |
Why?
|
| Cecal Diseases | 1 | 2010 | 49 | 0.090 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 2149 | 0.090 |
Why?
|
| Azathioprine | 1 | 2011 | 354 | 0.090 |
Why?
|
| Hyperplasia | 3 | 2009 | 1151 | 0.080 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2013 | 282 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2013 | 572 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3436 | 0.080 |
Why?
|
| Databases, Factual | 4 | 2020 | 8080 | 0.080 |
Why?
|
| Carcinoembryonic Antigen | 3 | 2016 | 338 | 0.080 |
Why?
|
| Angiotensin II | 1 | 2013 | 843 | 0.080 |
Why?
|
| Child | 13 | 2023 | 80917 | 0.080 |
Why?
|
| Professional Role | 1 | 2012 | 316 | 0.080 |
Why?
|
| Phthalazines | 2 | 2025 | 397 | 0.080 |
Why?
|
| Hyperhidrosis | 1 | 2009 | 34 | 0.080 |
Why?
|
| Sympathectomy | 1 | 2009 | 72 | 0.080 |
Why?
|
| Telepathology | 1 | 2009 | 77 | 0.080 |
Why?
|
| Watchful Waiting | 1 | 2013 | 492 | 0.080 |
Why?
|
| Lectins | 1 | 2011 | 490 | 0.080 |
Why?
|
| Genetic Testing | 3 | 2015 | 3591 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2003 | 2931 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3251 | 0.080 |
Why?
|
| Dissection | 1 | 2011 | 299 | 0.080 |
Why?
|
| Cecum | 1 | 2010 | 231 | 0.080 |
Why?
|
| Adipokines | 1 | 2011 | 309 | 0.080 |
Why?
|
| Liposomes | 2 | 2023 | 790 | 0.080 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 347 | 0.080 |
Why?
|
| Appendix | 1 | 2010 | 110 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2013 | 3390 | 0.080 |
Why?
|
| Intussusception | 1 | 2010 | 116 | 0.080 |
Why?
|
| Lipoma | 1 | 2011 | 296 | 0.080 |
Why?
|
| Cell Communication | 3 | 2024 | 1660 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2024 | 18065 | 0.080 |
Why?
|
| Radiography, Thoracic | 2 | 2015 | 1321 | 0.080 |
Why?
|
| Forecasting | 1 | 2017 | 2945 | 0.080 |
Why?
|
| Neoplasm Transplantation | 3 | 2019 | 2014 | 0.080 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2008 | 617 | 0.080 |
Why?
|
| Brachytherapy | 2 | 2008 | 1220 | 0.080 |
Why?
|
| Perivascular Epithelioid Cell Neoplasms | 1 | 2009 | 78 | 0.080 |
Why?
|
| Polyvinyls | 2 | 2007 | 154 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 2185 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 2008 | 0.080 |
Why?
|
| CpG Islands | 2 | 2009 | 1208 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2013 | 951 | 0.070 |
Why?
|
| Risk Factors | 10 | 2020 | 74944 | 0.070 |
Why?
|
| Herpesvirus 4, Human | 2 | 2016 | 1082 | 0.070 |
Why?
|
| Hematocrit | 1 | 2009 | 623 | 0.070 |
Why?
|
| Germ-Line Mutation | 3 | 2024 | 1885 | 0.070 |
Why?
|
| Bronchiectasis | 1 | 2009 | 141 | 0.070 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 2007 | 23 | 0.070 |
Why?
|
| ROC Curve | 4 | 2021 | 3628 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2015 | 2202 | 0.070 |
Why?
|
| Lymphoma | 1 | 2017 | 1898 | 0.070 |
Why?
|
| T-Lymphocytes | 2 | 2016 | 10266 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2013 | 2923 | 0.070 |
Why?
|
| Yttrium Radioisotopes | 1 | 2008 | 115 | 0.070 |
Why?
|
| Serine | 1 | 2011 | 831 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 1999 | 2401 | 0.070 |
Why?
|
| Bronchi | 3 | 2018 | 850 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2012 | 1266 | 0.070 |
Why?
|
| Endoscopy, Digestive System | 2 | 2009 | 358 | 0.070 |
Why?
|
| Benzimidazoles | 1 | 2012 | 864 | 0.070 |
Why?
|
| Pharmaceutical Solutions | 1 | 2007 | 15 | 0.070 |
Why?
|
| Epithelioid Cells | 1 | 2007 | 60 | 0.070 |
Why?
|
| Splenic Vein | 1 | 2007 | 30 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2017 | 9669 | 0.070 |
Why?
|
| Collagen | 3 | 2023 | 2643 | 0.070 |
Why?
|
| Pilot Projects | 6 | 2021 | 8741 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 4580 | 0.070 |
Why?
|
| Digestive System Neoplasms | 1 | 2007 | 82 | 0.070 |
Why?
|
| Gastrostomy | 1 | 2010 | 325 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 1890 | 0.070 |
Why?
|
| Thiazoles | 1 | 2014 | 1542 | 0.070 |
Why?
|
| Camptothecin | 1 | 2011 | 600 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2013 | 1599 | 0.070 |
Why?
|
| Lung Transplantation | 1 | 2016 | 1309 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2007 | 247 | 0.070 |
Why?
|
| Indoles | 2 | 2013 | 1836 | 0.070 |
Why?
|
| Cell Differentiation | 4 | 2019 | 11669 | 0.070 |
Why?
|
| Combined Modality Therapy | 5 | 2024 | 8542 | 0.070 |
Why?
|
| Remote Consultation | 1 | 2009 | 242 | 0.070 |
Why?
|
| Immune Complex Diseases | 1 | 2006 | 50 | 0.070 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2013 | 617 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2024 | 588 | 0.070 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2011 | 879 | 0.070 |
Why?
|
| Immunoglobulin G | 5 | 2011 | 4568 | 0.070 |
Why?
|
| Massachusetts | 1 | 2020 | 8890 | 0.070 |
Why?
|
| Molecular Imaging | 1 | 2013 | 826 | 0.070 |
Why?
|
| Arginine | 2 | 2023 | 932 | 0.070 |
Why?
|
| Spleen | 1 | 2013 | 2295 | 0.070 |
Why?
|
| Cell Polarity | 1 | 2010 | 639 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2018 | 2954 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2014 | 1542 | 0.070 |
Why?
|
| Gastroenteritis | 1 | 2008 | 235 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2014 | 719 | 0.070 |
Why?
|
| Embolization, Therapeutic | 2 | 2007 | 1402 | 0.070 |
Why?
|
| Immunoblotting | 3 | 2015 | 1647 | 0.070 |
Why?
|
| United States | 6 | 2021 | 73039 | 0.070 |
Why?
|
| Smoking | 3 | 2019 | 9092 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2017 | 2523 | 0.070 |
Why?
|
| Wound Healing | 2 | 2015 | 2809 | 0.070 |
Why?
|
| Urogenital Neoplasms | 1 | 2007 | 130 | 0.070 |
Why?
|
| Radiography, Abdominal | 1 | 2009 | 541 | 0.060 |
Why?
|
| Immunocompromised Host | 1 | 2011 | 863 | 0.060 |
Why?
|
| Incidence | 3 | 2024 | 21538 | 0.060 |
Why?
|
| Intestinal Obstruction | 1 | 2010 | 433 | 0.060 |
Why?
|
| RNA Interference | 4 | 2016 | 2832 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 3 | 2011 | 1523 | 0.060 |
Why?
|
| Blood Platelets | 1 | 2016 | 2479 | 0.060 |
Why?
|
| DNA Mismatch Repair | 1 | 2009 | 431 | 0.060 |
Why?
|
| Models, Animal | 5 | 2010 | 2120 | 0.060 |
Why?
|
| Hepatic Encephalopathy | 1 | 2007 | 144 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2017 | 5797 | 0.060 |
Why?
|
| Virus Latency | 1 | 2008 | 361 | 0.060 |
Why?
|
| Comorbidity | 1 | 2020 | 10590 | 0.060 |
Why?
|
| Maximum Tolerated Dose | 2 | 2024 | 899 | 0.060 |
Why?
|
| Cyclins | 1 | 2007 | 606 | 0.060 |
Why?
|
| Pancreatic Diseases | 1 | 2007 | 354 | 0.060 |
Why?
|
| Video Recording | 2 | 2009 | 976 | 0.060 |
Why?
|
| Iatrogenic Disease | 1 | 2008 | 552 | 0.060 |
Why?
|
| Workflow | 2 | 2022 | 860 | 0.060 |
Why?
|
| Time Factors | 7 | 2024 | 40218 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 3114 | 0.060 |
Why?
|
| Rectum | 1 | 2010 | 900 | 0.060 |
Why?
|
| Mesentery | 1 | 2005 | 202 | 0.060 |
Why?
|
| Ventricular Myosins | 1 | 2024 | 65 | 0.060 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2009 | 388 | 0.060 |
Why?
|
| Consensus | 3 | 2024 | 3212 | 0.060 |
Why?
|
| Energy Intake | 1 | 2012 | 2146 | 0.060 |
Why?
|
| Bleomycin | 2 | 2017 | 492 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 2360 | 0.060 |
Why?
|
| Microsurgery | 1 | 2010 | 800 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2017 | 3620 | 0.060 |
Why?
|
| Mevalonic Acid | 1 | 2024 | 46 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 2005 | 261 | 0.060 |
Why?
|
| Cell Line | 4 | 2021 | 15597 | 0.060 |
Why?
|
| Prosthesis Failure | 2 | 2015 | 1208 | 0.060 |
Why?
|
| Fibroblasts | 2 | 2024 | 4176 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 11928 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 2429 | 0.060 |
Why?
|
| Octamer Transcription Factors | 1 | 2023 | 18 | 0.060 |
Why?
|
| Health Personnel | 1 | 2017 | 3385 | 0.060 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2024 | 99 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 1837 | 0.050 |
Why?
|
| Creatinine | 1 | 2009 | 1918 | 0.050 |
Why?
|
| Carcinoma, Adenoid Cystic | 2 | 2019 | 263 | 0.050 |
Why?
|
| Ribosomal Protein S6 | 2 | 2013 | 70 | 0.050 |
Why?
|
| Keratins | 1 | 2005 | 499 | 0.050 |
Why?
|
| Hypesthesia | 1 | 2024 | 106 | 0.050 |
Why?
|
| International Agencies | 2 | 2016 | 244 | 0.050 |
Why?
|
| Communicable Diseases | 1 | 2012 | 874 | 0.050 |
Why?
|
| Clinical Trials as Topic | 3 | 2022 | 8054 | 0.050 |
Why?
|
| Pandemics | 2 | 2020 | 8748 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2024 | 2040 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2021 | 1996 | 0.050 |
Why?
|
| Genes, APC | 1 | 2003 | 145 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2019 | 1760 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2020 | 2227 | 0.050 |
Why?
|
| Contrast Media | 5 | 2019 | 5330 | 0.050 |
Why?
|
| Amyloidosis | 1 | 2010 | 878 | 0.050 |
Why?
|
| Prevalence | 2 | 2017 | 15869 | 0.050 |
Why?
|
| Sulfones | 2 | 2016 | 448 | 0.050 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2006 | 622 | 0.050 |
Why?
|
| Cell Survival | 3 | 2019 | 5777 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2007 | 1528 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 4712 | 0.050 |
Why?
|
| Genetic Heterogeneity | 2 | 2017 | 736 | 0.050 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2009 | 843 | 0.050 |
Why?
|
| Mediastinum | 1 | 2023 | 272 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2013 | 6004 | 0.050 |
Why?
|
| Interleukin-6 | 2 | 2024 | 3228 | 0.050 |
Why?
|
| Computational Biology | 3 | 2021 | 3568 | 0.050 |
Why?
|
| Inflammation | 5 | 2024 | 10873 | 0.050 |
Why?
|
| Injections | 3 | 2011 | 840 | 0.050 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2003 | 219 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2013 | 1985 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2008 | 2204 | 0.050 |
Why?
|
| Human papillomavirus 18 | 1 | 2022 | 125 | 0.050 |
Why?
|
| Intestinal Diseases | 1 | 2006 | 505 | 0.050 |
Why?
|
| Clozapine | 1 | 2005 | 509 | 0.050 |
Why?
|
| Serous Membrane | 1 | 2021 | 23 | 0.050 |
Why?
|
| Child, Preschool | 4 | 2017 | 42669 | 0.050 |
Why?
|
| Losartan | 1 | 2023 | 262 | 0.050 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2022 | 114 | 0.050 |
Why?
|
| Guanidines | 1 | 2022 | 194 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2007 | 1505 | 0.050 |
Why?
|
| Esters | 1 | 2022 | 212 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2021 | 4146 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 9561 | 0.050 |
Why?
|
| Serine Endopeptidases | 2 | 2020 | 1027 | 0.050 |
Why?
|
| Alcoholism | 1 | 2012 | 1980 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2021 | 219 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2019 | 8317 | 0.040 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2023 | 520 | 0.040 |
Why?
|
| Eosinophilia | 1 | 2005 | 556 | 0.040 |
Why?
|
| Mitotic Index | 1 | 2020 | 162 | 0.040 |
Why?
|
| Human papillomavirus 16 | 1 | 2022 | 268 | 0.040 |
Why?
|
| Ki-67 Antigen | 2 | 2016 | 630 | 0.040 |
Why?
|
| Risk | 1 | 2012 | 9613 | 0.040 |
Why?
|
| Genome, Human | 2 | 2015 | 4446 | 0.040 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2021 | 157 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2014 | 10760 | 0.040 |
Why?
|
| Aging | 1 | 2019 | 8744 | 0.040 |
Why?
|
| Autoantigens | 1 | 2024 | 890 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2007 | 1126 | 0.040 |
Why?
|
| Angiography | 1 | 2005 | 1597 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2008 | 1815 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2019 | 1247 | 0.040 |
Why?
|
| Troponin I | 1 | 2024 | 662 | 0.040 |
Why?
|
| Patient Selection | 1 | 2012 | 4260 | 0.040 |
Why?
|
| Receptors, CXCR | 1 | 2020 | 52 | 0.040 |
Why?
|
| Coronary Restenosis | 1 | 2003 | 396 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 1 | 2019 | 15 | 0.040 |
Why?
|
| Gene Dosage | 2 | 2015 | 1219 | 0.040 |
Why?
|
| North America | 2 | 2018 | 1289 | 0.040 |
Why?
|
| Infant | 3 | 2012 | 36535 | 0.040 |
Why?
|
| Chemokines | 1 | 2024 | 963 | 0.040 |
Why?
|
| Troponin T | 1 | 2024 | 787 | 0.040 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2019 | 72 | 0.040 |
Why?
|
| Mediastinal Neoplasms | 1 | 2002 | 403 | 0.040 |
Why?
|
| Hepatitis, Viral, Human | 1 | 1999 | 141 | 0.040 |
Why?
|
| Tissue Preservation | 1 | 1999 | 173 | 0.040 |
Why?
|
| Colitis, Ulcerative | 1 | 2011 | 1926 | 0.040 |
Why?
|
| Blood Group Incompatibility | 1 | 1999 | 134 | 0.040 |
Why?
|
| Pneumonectomy | 2 | 2020 | 1156 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 5889 | 0.040 |
Why?
|
| Gastroesophageal Reflux | 1 | 2006 | 836 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2022 | 465 | 0.040 |
Why?
|
| Enzyme Repression | 1 | 2018 | 30 | 0.040 |
Why?
|
| Recurrence | 4 | 2015 | 8509 | 0.040 |
Why?
|
| Cholangitis | 1 | 1999 | 110 | 0.040 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 325 | 0.040 |
Why?
|
| Hedgehog Proteins | 2 | 2016 | 771 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2007 | 2451 | 0.040 |
Why?
|
| Histocompatibility | 1 | 1999 | 321 | 0.040 |
Why?
|
| src Homology Domains | 1 | 2019 | 361 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2022 | 577 | 0.040 |
Why?
|
| Benzamides | 2 | 2015 | 1379 | 0.040 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2019 | 91 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2011 | 4206 | 0.040 |
Why?
|
| Ethylnitrosourea | 1 | 2018 | 50 | 0.040 |
Why?
|
| Hematoxylin | 1 | 2018 | 61 | 0.040 |
Why?
|
| Protease Inhibitors | 1 | 2022 | 751 | 0.040 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2018 | 70 | 0.040 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2018 | 101 | 0.040 |
Why?
|
| Coronary Disease | 1 | 2012 | 5919 | 0.040 |
Why?
|
| Virus Internalization | 1 | 2022 | 504 | 0.040 |
Why?
|
| Rhabdoid Tumor | 1 | 2020 | 211 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2020 | 457 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 330 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2007 | 1323 | 0.040 |
Why?
|
| Endothelial Cells | 2 | 2023 | 3589 | 0.040 |
Why?
|
| Point Mutation | 2 | 2015 | 1596 | 0.040 |
Why?
|
| Macrophages | 1 | 2013 | 5799 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2010 | 2171 | 0.040 |
Why?
|
| Sigmoidoscopy | 1 | 2018 | 150 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2016 | 2937 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2018 | 369 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2009 | 3329 | 0.040 |
Why?
|
| Transfection | 2 | 2016 | 5755 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2023 | 1143 | 0.040 |
Why?
|
| Endoderm | 1 | 2018 | 165 | 0.040 |
Why?
|
| Popliteal Cyst | 1 | 1996 | 8 | 0.040 |
Why?
|
| Medical Oncology | 2 | 2022 | 2346 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 801 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2024 | 22291 | 0.030 |
Why?
|
| Ischemia | 1 | 2005 | 1900 | 0.030 |
Why?
|
| Mucin-2 | 2 | 2008 | 50 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2271 | 0.030 |
Why?
|
| Oncogene Fusion | 1 | 2017 | 84 | 0.030 |
Why?
|
| Sus scrofa | 2 | 2010 | 430 | 0.030 |
Why?
|
| Amylases | 1 | 2016 | 171 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2017 | 404 | 0.030 |
Why?
|
| Genes, erbB-2 | 1 | 2017 | 162 | 0.030 |
Why?
|
| Gallium Radioisotopes | 1 | 2017 | 195 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2022 | 1140 | 0.030 |
Why?
|
| Cricoid Cartilage | 1 | 1996 | 69 | 0.030 |
Why?
|
| Pharyngeal Muscles | 1 | 1996 | 81 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2019 | 1162 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2007 | 3216 | 0.030 |
Why?
|
| Purines | 1 | 2019 | 615 | 0.030 |
Why?
|
| Thrombophlebitis | 1 | 1996 | 289 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1999 | 528 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2016 | 144 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2016 | 166 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2021 | 1194 | 0.030 |
Why?
|
| Dermatologic Agents | 1 | 2020 | 313 | 0.030 |
Why?
|
| Cisplatin | 2 | 2019 | 1660 | 0.030 |
Why?
|
| Neprilysin | 2 | 2009 | 487 | 0.030 |
Why?
|
| Genes, cdc | 1 | 2016 | 113 | 0.030 |
Why?
|
| Ovary | 1 | 2020 | 965 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 1625 | 0.030 |
Why?
|
| Sirolimus | 2 | 2013 | 1540 | 0.030 |
Why?
|
| Cell Count | 2 | 2012 | 1832 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2024 | 2568 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2020 | 812 | 0.030 |
Why?
|
| Cystadenoma | 1 | 2015 | 77 | 0.030 |
Why?
|
| Bronchography | 1 | 1995 | 74 | 0.030 |
Why?
|
| Injections, Intralesional | 2 | 2006 | 280 | 0.030 |
Why?
|
| Imidazoles | 1 | 2021 | 1169 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2021 | 1336 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 2631 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2020 | 729 | 0.030 |
Why?
|
| Forms and Records Control | 1 | 2016 | 158 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2019 | 9384 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 1754 | 0.030 |
Why?
|
| Genes, p16 | 1 | 2015 | 159 | 0.030 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2015 | 69 | 0.030 |
Why?
|
| Genes, myc | 1 | 2016 | 391 | 0.030 |
Why?
|
| Obesity | 1 | 2017 | 13090 | 0.030 |
Why?
|
| Regeneration | 2 | 2015 | 1524 | 0.030 |
Why?
|
| World Health Organization | 1 | 2021 | 1329 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2019 | 751 | 0.030 |
Why?
|
| Cysteine | 1 | 2019 | 897 | 0.030 |
Why?
|
| Computer-Assisted Instruction | 1 | 2017 | 366 | 0.030 |
Why?
|
| Database Management Systems | 1 | 2016 | 263 | 0.030 |
Why?
|
| Filtration | 1 | 2015 | 229 | 0.030 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2014 | 147 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2007 | 4937 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2019 | 778 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2019 | 965 | 0.030 |
Why?
|
| Organoplatinum Compounds | 1 | 2016 | 408 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2014 | 109 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2013 | 5027 | 0.030 |
Why?
|
| Choroid Neoplasms | 1 | 1995 | 177 | 0.030 |
Why?
|
| Hepatitis B | 1 | 1999 | 711 | 0.030 |
Why?
|
| Receptor, erbB-2 | 2 | 2015 | 2603 | 0.030 |
Why?
|
| DNA | 1 | 2007 | 7214 | 0.030 |
Why?
|
| Collagen Diseases | 1 | 1994 | 39 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 1196 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 451 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2018 | 1081 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2004 | 2056 | 0.030 |
Why?
|
| Age Factors | 3 | 2017 | 18412 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2015 | 368 | 0.030 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2015 | 304 | 0.030 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2014 | 201 | 0.030 |
Why?
|
| Pharynx | 1 | 1996 | 436 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2017 | 772 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2024 | 2747 | 0.030 |
Why?
|
| Molecular Probe Techniques | 1 | 2013 | 111 | 0.030 |
Why?
|
| Click Chemistry | 1 | 2013 | 101 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2018 | 724 | 0.030 |
Why?
|
| Acute Disease | 3 | 2015 | 7243 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2019 | 2234 | 0.030 |
Why?
|
| Teaching | 1 | 2020 | 1171 | 0.030 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2012 | 38 | 0.030 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2012 | 17 | 0.030 |
Why?
|
| Pyrophosphatases | 1 | 2013 | 142 | 0.030 |
Why?
|
| Hospitals, General | 1 | 2017 | 809 | 0.030 |
Why?
|
| Ilium | 1 | 2013 | 155 | 0.030 |
Why?
|
| Neuregulin-1 | 1 | 2013 | 136 | 0.030 |
Why?
|
| Thymidylate Synthase | 1 | 2012 | 74 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 464 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 531 | 0.030 |
Why?
|
| Mitochondria | 2 | 2017 | 3681 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 638 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 2016 | 571 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1230 | 0.020 |
Why?
|
| Hepatectomy | 2 | 2006 | 588 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2020 | 2872 | 0.020 |
Why?
|
| Thymectomy | 1 | 2012 | 200 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2005 | 3081 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2012 | 188 | 0.020 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2011 | 38 | 0.020 |
Why?
|
| Sternotomy | 1 | 2012 | 132 | 0.020 |
Why?
|
| Callitrichinae | 1 | 2011 | 20 | 0.020 |
Why?
|
| Heart | 1 | 2024 | 4446 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2015 | 1587 | 0.020 |
Why?
|
| Cadherins | 1 | 2016 | 905 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2253 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 4793 | 0.020 |
Why?
|
| Paresthesia | 1 | 2012 | 160 | 0.020 |
Why?
|
| Ketoglutaric Acids | 1 | 2011 | 76 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 381 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1606 | 0.020 |
Why?
|
| Postoperative Complications | 5 | 2015 | 15832 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2020 | 2323 | 0.020 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2012 | 119 | 0.020 |
Why?
|
| Radiotherapy Dosage | 2 | 2010 | 2916 | 0.020 |
Why?
|
| Sarcoidosis | 1 | 1996 | 535 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2016 | 872 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2019 | 3160 | 0.020 |
Why?
|
| Gastroscopes | 1 | 2010 | 20 | 0.020 |
Why?
|
| Reoperation | 1 | 2021 | 4329 | 0.020 |
Why?
|
| Proteomics | 1 | 2024 | 3912 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 615 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2015 | 698 | 0.020 |
Why?
|
| Kidney | 3 | 2017 | 7064 | 0.020 |
Why?
|
| Sphingosine | 1 | 2013 | 308 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4283 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2012 | 278 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2012 | 472 | 0.020 |
Why?
|
| Hamartoma | 1 | 2013 | 236 | 0.020 |
Why?
|
| Veratrum Alkaloids | 1 | 2010 | 23 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2013 | 714 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 1483 | 0.020 |
Why?
|
| Lysophospholipids | 1 | 2013 | 338 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 4786 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 1743 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 1996 | 640 | 0.020 |
Why?
|
| Reference Standards | 1 | 2014 | 1014 | 0.020 |
Why?
|
| Citric Acid Cycle | 1 | 2011 | 234 | 0.020 |
Why?
|
| Exons | 1 | 2016 | 2394 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 2016 | 2227 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 1001 | 0.020 |
Why?
|
| Bronchiolitis | 1 | 1996 | 492 | 0.020 |
Why?
|
| Western World | 1 | 2009 | 27 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2011 | 332 | 0.020 |
Why?
|
| Receptors, Growth Factor | 1 | 2010 | 324 | 0.020 |
Why?
|
| Syncope | 1 | 2012 | 430 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2022 | 3073 | 0.020 |
Why?
|
| Cell Separation | 1 | 2015 | 1728 | 0.020 |
Why?
|
| Hemoptysis | 1 | 2010 | 152 | 0.020 |
Why?
|
| Hepatitis C | 1 | 1999 | 1595 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1738 | 0.020 |
Why?
|
| Esophagitis | 1 | 2010 | 164 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 1901 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2017 | 2393 | 0.020 |
Why?
|
| Boston | 2 | 2017 | 9374 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 2414 | 0.020 |
Why?
|
| Serologic Tests | 1 | 2011 | 382 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 1750 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2014 | 3590 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2009 | 271 | 0.020 |
Why?
|
| Family | 1 | 1999 | 3209 | 0.020 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2010 | 167 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2011 | 963 | 0.020 |
Why?
|
| Foreign-Body Migration | 1 | 2010 | 220 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1892 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2017 | 2055 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2011 | 704 | 0.020 |
Why?
|
| Cytarabine | 1 | 2010 | 695 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2012 | 1419 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3055 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2014 | 2357 | 0.020 |
Why?
|
| Prescriptions | 1 | 2010 | 388 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2008 | 193 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2019 | 3706 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2009 | 374 | 0.020 |
Why?
|
| Venous Pressure | 1 | 2007 | 55 | 0.020 |
Why?
|
| Anal Canal | 1 | 2010 | 376 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 874 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 2735 | 0.020 |
Why?
|
| Computer Systems | 1 | 2008 | 469 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 6231 | 0.020 |
Why?
|
| Submandibular Gland | 1 | 2006 | 85 | 0.020 |
Why?
|
| Abscess | 1 | 2010 | 606 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 3610 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 1169 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3800 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2013 | 1758 | 0.020 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2011 | 620 | 0.020 |
Why?
|
| Pressure | 1 | 2010 | 1172 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2005 | 6983 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2019 | 13053 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 2396 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2010 | 991 | 0.020 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2006 | 64 | 0.020 |
Why?
|
| Cytokines | 1 | 2021 | 7453 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2011 | 1563 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2011 | 789 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 2011 | 667 | 0.020 |
Why?
|
| Rats | 1 | 2022 | 23760 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2007 | 453 | 0.020 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2011 | 454 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 1062 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2011 | 1191 | 0.020 |
Why?
|
| Keratin-20 | 1 | 2005 | 31 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2009 | 1609 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 1942 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 1140 | 0.020 |
Why?
|
| Genetic Variation | 2 | 2012 | 6611 | 0.020 |
Why?
|
| Keratin-7 | 1 | 2005 | 55 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 3956 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 1074 | 0.020 |
Why?
|
| Lasers | 1 | 2009 | 952 | 0.020 |
Why?
|
| Databases, Bibliographic | 1 | 2005 | 128 | 0.020 |
Why?
|
| RNA | 1 | 2015 | 2720 | 0.020 |
Why?
|
| Pyloric Antrum | 1 | 2005 | 66 | 0.020 |
Why?
|
| International Cooperation | 1 | 2011 | 1436 | 0.020 |
Why?
|
| Registries | 1 | 2021 | 8375 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 2006 | 513 | 0.010 |
Why?
|
| Cell Division | 1 | 2012 | 4473 | 0.010 |
Why?
|
| Genome, Viral | 1 | 2008 | 674 | 0.010 |
Why?
|
| Point-of-Care Systems | 1 | 2013 | 1238 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5367 | 0.010 |
Why?
|
| Hypotension | 1 | 2010 | 888 | 0.010 |
Why?
|
| Longevity | 1 | 2012 | 1077 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2009 | 944 | 0.010 |
Why?
|
| Blood Sedimentation | 1 | 2005 | 236 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2011 | 1480 | 0.010 |
Why?
|
| Paraffin Embedding | 1 | 2005 | 307 | 0.010 |
Why?
|
| Curriculum | 1 | 2017 | 3782 | 0.010 |
Why?
|
| Adenoma, Villous | 1 | 2003 | 13 | 0.010 |
Why?
|
| Glutens | 1 | 2006 | 240 | 0.010 |
Why?
|
| Protein Binding | 1 | 2016 | 9343 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2008 | 1715 | 0.010 |
Why?
|
| Software | 1 | 2018 | 4478 | 0.010 |
Why?
|
| Intestinal Neoplasms | 1 | 2006 | 314 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2016 | 3080 | 0.010 |
Why?
|
| Bacteremia | 1 | 2010 | 986 | 0.010 |
Why?
|
| Alleles | 1 | 2014 | 6894 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 3833 | 0.010 |
Why?
|
| Goblet Cells | 1 | 2006 | 300 | 0.010 |
Why?
|
| Catheterization | 1 | 2008 | 1430 | 0.010 |
Why?
|
| Peptides | 1 | 2015 | 4354 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 1534 | 0.010 |
Why?
|
| Defibrillators, Implantable | 1 | 2012 | 1498 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1996 | 2599 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9615 | 0.010 |
Why?
|
| Pelvis | 1 | 2007 | 736 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 4055 | 0.010 |
Why?
|
| Atherectomy, Coronary | 1 | 2003 | 138 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2011 | 2493 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2012 | 2258 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2010 | 4030 | 0.010 |
Why?
|
| Anemia | 1 | 2012 | 1514 | 0.010 |
Why?
|
| Equipment Design | 1 | 2010 | 3522 | 0.010 |
Why?
|
| Morbidity | 1 | 2007 | 1755 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2017 | 4858 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2011 | 2235 | 0.010 |
Why?
|
| Abdomen | 1 | 2007 | 1136 | 0.010 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2010 | 1679 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 2007 | 1171 | 0.010 |
Why?
|
| Weight Loss | 1 | 2012 | 2721 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 3409 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7598 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 4352 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 2003 | 635 | 0.010 |
Why?
|
| Research Design | 1 | 2015 | 6211 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 3445 | 0.010 |
Why?
|
| Endovascular Procedures | 1 | 2012 | 2216 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 5505 | 0.010 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2002 | 350 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 30256 | 0.010 |
Why?
|
| Food Hypersensitivity | 1 | 2006 | 734 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 26379 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 12421 | 0.010 |
Why?
|
| Tin Compounds | 1 | 1996 | 8 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 3683 | 0.010 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 1996 | 67 | 0.010 |
Why?
|
| Length of Stay | 1 | 2010 | 6498 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 17622 | 0.010 |
Why?
|
| Vindesine | 1 | 1995 | 12 | 0.010 |
Why?
|
| Pedigree | 1 | 2003 | 4539 | 0.010 |
Why?
|
| Poliomyelitis | 1 | 1996 | 91 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 19015 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 16045 | 0.010 |
Why?
|
| Phlebography | 1 | 1996 | 326 | 0.010 |
Why?
|
| Sex Factors | 1 | 2009 | 10632 | 0.010 |
Why?
|
| Mitomycin | 1 | 1995 | 261 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1996 | 677 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2004 | 3514 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1996 | 2000 | 0.010 |
Why?
|
| Carboplatin | 1 | 1995 | 797 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 15948 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2003 | 4541 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 12252 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 1995 | 4282 | 0.000 |
Why?
|